> Caution is advi sed when BISPHOSPHONATE s are a dministe red with aminoglyc osides,  calcitoni n or LOOP DIURETICS , since these  agents may have an additive effect, resulting in a lower s erum CALCIUM level for longer periods than required  (see section 4. 4). 
> Cauti on is advised when ZOLEDRONIC ACID HOSPIRA is administered with anti -angiogenic medicinal products , as an increase in the incidence of ONJ has bee n observed in patients treated conco mitantly with these med icinal products .
